Page last updated: 2024-08-23

ursodeoxycholic acid and Biliary Fistula

ursodeoxycholic acid has been researched along with Biliary Fistula in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araki, T; Hirabayashi, N; Ishizaki, K; Iwaki, T; Kasai, H; Maeda, M; Miyazawa, N; Sakakura, H; Takeuchi, Y1
Brunetti, G; Garuti, C; Montosi, G; Panini, R; Pietrangelo, A; Salvioli, G; Tauschel, H; Vandelli, M; Ventura, P1
Clerici, C; Distrutti, E; Dozzini, G; Gentili, G; Natalini, B; Pelli, MA; Pellicciari, R; Rizzoli, R; Roda, A; Sadeghpour, BM1
Cohen, BI; Hagey, LR; Hofmann, AF; McSherry, CK; Mosbach, EH; Schteingart, CD; Yoshii, M1
Ceryak, S; Fromm, H; Malavolti, M; Shehan, KL1
Ceryak, S; Fromm, H; Malavolti, M1

Other Studies

6 other study(ies) available for ursodeoxycholic acid and Biliary Fistula

ArticleYear
The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
    European journal of pharmacology, 1998, Dec-11, Volume: 363, Issue:1

    Topics: Animals; Bicarbonates; Bile; Bile Acids and Salts; Biliary Fistula; Biomarkers; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Rats; Rats, Wistar; Time Factors; Ursodeoxycholic Acid

1998
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats.
    Pharmacology, 2001, Volume: 62, Issue:2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; beta-Cyclodextrins; Bile; Biliary Fistula; Biological Availability; Chemistry, Pharmaceutical; Cyclodextrins; Drug Combinations; Male; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid

2001
Effect of intraduodenal administration of 23-methyl-UDCA diastereoisomers on bile flow in hamsters.
    Digestive diseases and sciences, 1992, Volume: 37, Issue:5

    Topics: Acute Disease; Animals; Bicarbonates; Bile; Biliary Fistula; Biotransformation; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Duodenum; Liver; Male; Mesocricetus; Stereoisomerism; Structure-Activity Relationship; Ursodeoxycholic Acid

1992
Chemical synthesis and hepatic biotransformation of 3 alpha,7 alpha-dihydroxy-7 beta-methyl-24-nor-5 beta-cholan-23-oic acid, a 7-methyl derivative of norchenodeoxycholic acid: studies in the hamster.
    Journal of lipid research, 1991, Volume: 32, Issue:11

    Topics: Animals; Biliary Fistula; Biotransformation; Cholagogues and Choleretics; Chromatography, Thin Layer; Cricetinae; Kinetics; Liver; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mesocricetus; Ursodeoxycholic Acid

1991
Effects of bile acid depletion and of ursodeoxycholic and chenodeoxycholic acids on biliary protein secretion in the hamster.
    Life sciences, 1990, Volume: 46, Issue:23

    Topics: Animals; Bile; Bile Acids and Salts; Biliary Fistula; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chromatography, Gas; Cricetinae; Deoxycholic Acid; Disease Models, Animal; Lithocholic Acid; Male; Mesocricetus; Proteins; Ursodeoxycholic Acid

1990
Modulation of bile secretion by hepatic low-density lipoprotein uptake and by chenodeoxycholic acid and ursodeoxycholic acid treatment in the hamster.
    Gastroenterology, 1987, Volume: 93, Issue:5

    Topics: Animals; Apolipoproteins; Bile; Biliary Fistula; Chenodeoxycholic Acid; Cricetinae; Deoxycholic Acid; Diet; Enterohepatic Circulation; Lipoproteins, LDL; Liver; Male; Mesocricetus; Receptors, Cell Surface; Receptors, Lipoprotein; Ursodeoxycholic Acid

1987